3'-Hydroxy Repaglinide-d5

• CAT Number: S000916
• CAS Number: 1352792-15-4
• Molecular Formula: C27H31D5N2O5
• Molecular Weight: 473.62
• Purity: ≥95%
• IUPAC Name: 4-[2-[[1-[2-(3-hydroxypiperidin-1-yl)phenyl]-3-methylbutyl]amino]-2-oxoethyl]-2-(1,1,2,2,2-pentadeuterioethoxy)benzoic acid
• InChI: InChI=1S/C27H36N2O5/c1-4-34-25-15-19(11-12-22(25)27(32)33)16-26(31)28-23(14-18(2)3)21-9-5-6-10-24(21)29-13-7-8-20(30)17-29/h5-6,9-12,15,18,20,23,30H,4,7-8,13-14,16-17H2,1-3H3,(H,28,31)(H,32,33)/i1D3,4D2
• InChIKey: OBMAZJVHPAVADF-SGEUAGPISA-N
• SMILES: [2H]C([2H])([2H])C([2H])([2H])OC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCC(C3)O)C(=O)O

3′-Hydroxy Repaglinide-d5 is a high-purity deuterated compound essential for advanced pharmaceutical and biochemical research. This isotopically labeled version of 3′-Hydroxy Repaglinide, featuring five deuterium atoms, is crucial for studies involving diabetes drug metabolism, pharmacokinetics, and drug interaction analysis. Its stable isotope labeling ensures precise and reliable analytical results. With enhanced stability and consistency, it is suitable for various experimental setups. Ideal for antidiabetic research and drug development, 3′-Hydroxy Repaglinide-d5 integrates seamlessly into existing protocols, offering a robust and cost-effective solution for high-precision scientific investigations.